Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Gains from Sales and Divestitures (2021 - 2025)

LifeStance Health (LFST) has disclosed Gains from Sales and Divestitures for 5 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • Quarterly Gains from Sales and Divestitures rose 50438.46% to $6.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Dec 2025, up 50438.46% year-over-year, with the annual reading at $6.6 million for FY2025, 50438.46% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $6.6 million at LifeStance Health, up from $6.1 million in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $7.1 million in Q3 2024, with the low at $1711.0 in Q1 2023.
  • Average Gains from Sales and Divestitures over 5 years is $2.2 million, with a median of $9247.0 recorded in 2023.
  • The sharpest move saw Gains from Sales and Divestitures plummeted 99.16% in 2023, then soared 332278.73% in 2024.
  • Over 5 years, Gains from Sales and Divestitures stood at $7265.0 in 2021, then fell by 12.7% to $6342.0 in 2022, then soared by 45.81% to $9247.0 in 2023, then surged by 40.59% to $13000.0 in 2024, then surged by 50438.46% to $6.6 million in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $6.6 million, $6.1 million, and $13000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.